
1. stem cell res. 2019 aug;39:101484. doi: 10.1016/j.scr.2019.101484. epub 2019 jun 
14.

generation characterization induced pluripotent stem cell line
(igibi001-a) sickle cell anemia patient homozygous β-globin mutation.

bhargava n(1), jaitly s(1), goswami sg(2), jain s(3), chakraborty d(2),
ramalingam s(4).

author information: 
(1)csir- institute genomics integrative biology, mathura road, sukhdev
vihar, new delhi, india.
(2)csir- institute genomics integrative biology, mathura road, sukhdev
vihar, new delhi, india; academy scientific innovative research (acsir),
new delhi, india.
(3)thalassemia sickle cell society, rajendra nagar, hyderabad, india.
(4)csir- institute genomics integrative biology, mathura road, sukhdev
vihar, new delhi, india; academy scientific innovative research (acsir),
new delhi, india. electronic address: sivaramalingam@igib.res.in.

sickle cell disease (scd) autosomal recessive disorder caused mutation
in β-globin (hbb) gene. generated induced pluripotent stem cell (ipsc)
line, igibi001-a indian sickle cell patient homozygous hbb gene
mutation using sendai virus reprogramming system. characterization igibi001-a 
showed ipscs transgene-free expressed pluripotent stem cell
markers. normal karyotype able differentiate all
three germ layers. new scd-ipsc line contribute better understanding
of disease biology sickle cell anemia screening small molecule 
drugs.

copyright © 2019 authors. published elsevier b.v. rights reserved.

doi: 10.1016/j.scr.2019.101484 
pmid: 31255831  [indexed medline]

